UBS has moved Sherwin-Williams to Neutral from Buy, trimming the brokerage's 12-month price target to $330 a share from $385. The change follows UBS's view that a sustained downturn in the U.S. housing market will push back the company’s earnings rebound to no earlier than 2028.
The bank now projects Sherwin-Williams’ earnings per share will grow at roughly 5% annually over the next two years, a pace meaningfully below the company’s historical trajectory. UBS pointed to a set of persistent headwinds - higher mortgage rates, stubborn inflation, and weak housing affordability - that continue to suppress home sales and reduce repainting demand.
UBS emphasized Sherwin-Williams’ exposure to residential markets through its Paint Stores Group, which the bank estimates accounts for approximately 70% of the company’s earnings. That concentration leaves the firm highly leveraged to the health of U.S. housing activity, and UBS’s analysts say they do not expect a material recovery in housing before 2028.
Despite the soft end markets, Sherwin-Williams has managed to hold volumes relatively steady by capturing market share and exercising pricing power. UBS expects price increases to keep helping offset inflationary pressures, but the bank cautioned that pricing alone is unlikely to produce a sharp acceleration in earnings in the near term.
A central concern behind the downgrade is Sherwin-Williams’ reported participation in a joint bid for portions of Dutch coatings group AkzoNobel. UBS estimates that such an acquisition could lift earnings by about 7 to 10% after synergies are realized. At the same time, the bank warned the deal could push the company’s leverage to north of 3x EBITDA and tilt the earnings mix away from the higher-growth Paint Stores franchise toward lower-growth industrial coatings operations.
UBS also flagged the market implication of a large deal. The bank expects investors might apply a lower valuation multiple to Sherwin-Williams if the company increases leverage and shifts into more industrial exposure, which could translate into a share-price derating of approximately 10%.
Even as UBS grows more cautious on the company’s near-term outlook, it retains a constructive long-term stance. The bank forecasts that once housing markets recover, Sherwin-Williams could enter a period of multi-year, double-digit earnings growth. UBS projects earnings growth accelerating to nearly 20% annually from 2028 onward, supported by stronger demand, continued market-share gains, and easing raw-material costs.
For now, UBS says the stock lacks a clear catalyst and is likely to trade in a range until there is greater clarity on either a U.S. housing recovery or the company’s acquisition plans.